Safety, Adherence and Acceptability of Intermittent Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis (PrEP) among HIV-Uninfected Ugandan Volunteers Living in HIV-Serodiscordant Relationships: A Randomized, Clinical Trial

Safety, Adherence and Acceptability of Intermittent Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis (PrEP) among HIV-Uninfected Ugandan Volunteers Living in HIV-Serodiscordant Relationships: A Randomized, Clinical Trial

Bibliographic Details
Main Authors: Kibengo, Freddie M., Ruzagira, Eugene, Katende, David, Bwanika, Agnes N., Bahemuka, Ubaldo, Haberer, Jessica E., Bangsberg, David R., Barin, Burc, Rooney, James F., Mark, David, Chetty, Paramesh, Fast, Patricia, Kamali, Anatoli, Priddy, Frances H.
Format: Online
Language:English
Published: Public Library of Science 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784443/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784443/

Similar Items